Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.50 |
| ▸ | RECQL | P46063 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 3/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | RAB9A | P51151 | 2/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2311235 | 0.90 | TSHR (0.44) | TSHRRECQLALDH1A1SMN1; SMN2KDM4E | |
| SCHEMBL3990594 | 0.88 | ALDH1A1 (0.42) | TSHRALDH1A1SMN1; SMN2KDM4EMAPT | |
| SCHEMBL12764466 | 0.88 | ALDH1A1 (0.42) | TSHRALDH1A1SMN1; SMN2KDM4EMAPT | |
| SCHEMBL28869446 | 0.84 | ALDH1A1 (0.40) | TSHRALDH1A1SMN1; SMN2HSD17B10LMNA | |
| SCHEMBL1198791 | 0.83 | SMN1; SMN2 (0.49) | TSHRRECQLALDH1A1SMN1; SMN2KDM4E | |
| SCHEMBL2038297 | 0.83 | GAA (0.41) | TSHRALDH1A1SMN1; SMN2KDM4EHSD17B10 | |
| SCHEMBL9422139 | 0.81 | KDM4E (0.43) | TSHRALDH1A1SMN1; SMN2KDM4EHSD17B10 | |
| SCHEMBL2909869 | 0.79 | TSHR (0.57) | TSHRRECQLALDH1A1SMN1; SMN2KDM4E | |
| SCHEMBL7058008 | 0.78 | TSHR (0.47) | TSHRRECQLALDH1A1SMN1; SMN2KDM4E | |
| SCHEMBL7058013 | 0.78 | TSHR (0.47) | TSHRRECQLALDH1A1SMN1; SMN2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2906242-A1 | DELIVERY OF SMALL INTERFERING RNA AND MICRO RNA THROUGH MEMBRANE-DISRUPTIVE, RESPONSIVE NANOSCALLE HYDROGELS | Board Of Regents, The University Of Texas System (US) | 2015-08-19 | — | — | EP | claimed |
| US-20150216814-A1 | DELIVERY OF SMALL INTERFERING RNA AND MICRO RNA THROUGH MEMBRANE-DISRUPTIVE, RESPONSIVE NANOSCALLE HYDROGELS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2015-08-06 | — | — | US | claimed |
| EP-0226542-A2 | Holograms | ILFORD Limited (GB) | 1987-06-24 | — | — | EP | claimed |
| US-11649413-B2 | Lubricating oil composition for internal combustion engine | ENEOS CORPORATION (JP) | 2023-05-16 | — | — | US | disclosed |
| US-11274262-B2 | Lubricating oil composition and use method therefor | IDEMITSU KOSAN CO., LTD. (JP) | 2022-03-15 | — | — | US | disclosed |
| US-20210214640-A1 | LUBRICATING OIL COMPOSITION FOR INTERNAL COMBUSTION ENGINE | ENEOS CORPORATION (JP) | 2021-07-15 | — | — | US | disclosed |
| US-11000602-B2 | Delivery of small interfering RNA and micro RNA through nanogels containing hydrophobic pseudo-peptides | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2021-05-11 | — | — | US | disclosed |
| US-20210032559-A1 | LUBRICATING OIL COMPOSITION AND USE METHOD THEREFOR | IDEMITSU KOSAN CO.,LTD. (JP) | 2021-02-04 | — | — | US | disclosed |
| CN-106471106-B | Lubricating oil composition for transmission | 捷客斯能源株式会社 | 2020-03-03 | — | — | CN | disclosed |
| CN-107075015-B | Surfactant-compatibility star-like macromolecules | 派诺聚合物技术公司 | 2019-08-23 | — | — | CN | disclosed |
| CN-109091460-A | Anti-viral pharmaceutical compositions | 阿尔塔纳米产品有限公司 | 2018-12-28 | — | — | CN | disclosed |
| US-6313191-B1 | USED FOR ADHERING TO DENTAL TOOTH SURFACE | DENTSPLY GMBH (DE) | 2001-11-06 | — | — | US | disclosed |
| EP-1055722-A1 | OIL COMPOSITION FOR NON-STAGE TRANSMISSION | Japan Energy Corporation (JP) | 2000-11-29 | — | — | EP | disclosed |
| US-5838863-A | WATER ABSORBENT ADDITION POLYMER RESIN | SANYO CHEMICAL INDUSTRIES, LTD. (JP) | 1998-11-17 | — | — | US | disclosed |
| US-5756559-A | Method and composition for adhering to tooth structure | DENTSPLY RESEARCH & DEVELOPMENT (US) | 1998-05-26 | — | — | US | disclosed |
| EP-0790265-A1 | Sealing material for cable and cable using the same | SANYO CHEMICAL INDUSTRIES, Ltd. (JP) | 1997-08-20 | — | — | EP | disclosed |
| EP-0765758-A2 | Ink-jet recording process, and ink-jet recording apparatus | CANON KABUSHIKI KAISHA (JP) | 1997-04-02 | — | — | EP | disclosed |
| EP-0360617-A2 | Dry toner, dry developer and process for forming images | Hitachi Chemical Co., Ltd. (JP) | 1990-03-28 | — | — | EP | disclosed |
| EP-0226542-A2 | Holograms | ILFORD Limited (GB) | 1987-06-24 | — | — | EP | disclosed |
| US-4074051-A | DEVELOPING AGENTS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1978-02-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11000602-B2 | Delivery of small interfering RNA and micro RNA through nanogels containing hydrophobic pseudo-peptides | HNRNPH3, SNRPE, MSN | TSHR 1812/4885RECQL 2635/4885ALDH1A1 4702/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.